NASDAQ: OKYO
Okyo Pharma Ltd Stock Ownership - Who owns Okyo Pharma?

Insider buying vs selling

Have Okyo Pharma Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gabriele M. CerroneDirector2026-06-08300,000$1.72
$516.00kBuy

1 of 1

OKYO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OKYO insiders and whales buy or sell their stock.

OKYO Shareholders

What type of owners hold Okyo Pharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gabriele M. Cerrone1,468.06%564,534,047$858.09MInsider
Woodline Partners LP9.50%3,652,190$5.55MInstitution
Maven Securities Ltd3.06%1,175,535$1.79MInstitution
Stonepine Capital Management LLC2.21%850,000$1.29MInstitution
Balyasny Asset Management LP1.52%584,796$888.89kInstitution
Gary S. Jacob0.28%108,920$165.56kInsider
Ubs Group Ag0.16%59,760$90.84kInstitution
Xtx Topco Ltd0.10%37,652$57.23kInstitution
John P. Brancaccio0.08%30,201$45.91kInsider
Keeren Rameshchandra Shah0.04%16,667$25.33kInsider

1 of 2

OKYO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OKYO1.12%98.88%Net BuyingNet Buying
PMVP58.61%41.39%Net Selling
MCRB3.32%96.68%Net SellingNet Selling
ENTX15.99%16.15%Net Buying
INKT0.52%99.48%Net BuyingNet Buying

Okyo Pharma Stock Ownership FAQ

Who owns Okyo Pharma?

Okyo Pharma (NASDAQ: OKYO) is owned by 16.62% institutional shareholders, 1,468.50% Okyo Pharma insiders, and 0.00% retail investors. Gabriele M. Cerrone is the largest individual Okyo Pharma shareholder, owning 564.53M shares representing 1,468.06% of the company. Gabriele M. Cerrone's Okyo Pharma shares are currently valued at $846.80M.

If you're new to stock investing, here's how to buy Okyo Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.